Discontinued — last reported Q4 '14
Eli Lilly Investment Purchases decreased by 15.4% to $127.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 16.6%, from $152.20M to $127.00M. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows a downward trend with a -8.7% CAGR.
High volume indicates the company has significant excess cash from operations that it is parking in interest-bearing or liquid instruments.
The total cash spent on purchasing liquid financial instruments, such as corporate bonds, government securities, or othe...
Cash-rich companies like Microsoft and Apple frequently move billions between cash and short-term investment accounts.
cf_purchases_of_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.20M | $1.30M | $902.00M | $14.60M | $18.30M | $32.10M | $535.20M | $146.00M | $197.40M | $131.40M | $256.00M | $117.10M | $133.00M | $275.00M | $152.20M | $196.70M | $171.20M | $150.10M | $127.00M |
| QoQ Change | — | -81.9% | >999% | -98.4% | +25.3% | +75.4% | >999% | -72.7% | +35.2% | -33.4% | +94.8% | -54.3% | +13.6% | +106.8% | -44.7% | +29.2% | -13.0% | -12.3% | -15.4% |
| YoY Change | — | — | — | — | +154.2% | >999% | -40.7% | +900.0% | +978.7% | +309.3% | -52.2% | -19.8% | -32.6% | +109.3% | -40.5% | +68.0% | +28.7% | -45.4% | -16.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.